Literature DB >> 21670089

Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis.

Lorena Álvarez Rodríguez1, Marcos López-Hoyos, Cristina Mata, Ana Fontalba, Jaime Calvo Alen, María José Marín, José Luis Fernández-Luna, Jesús Aguero Balbín, Maitane Aranzamendi Zaldunbide, Ricardo Blanco, Víctor M Martínez-Taboada.   

Abstract

OBJECTIVE: To investigate the expression and function of the Toll-like receptor (TLR) family in peripheral blood mononuclear cells (PBMCs) of patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
METHODS: The authors analysed 70 patients with PMR, 20 with GCA, and 24 healthy controls (HC). TLR expression was assessed by flow cytometry. TLR function was assessed by stimulating PBMCs with specific ligands.
RESULTS: A significantly increased expression of TLR7 in PBMCs of patients with active disease compared with HC was found. Despite increased expression of TLR7, circulating monocytes from patients showed a significantly lower in vitro response to TLR7 agonists. No amino acid substitutions predicted to be functionally damaging were found in TLR7. A normal response to specific TLR7 agonists in patients in complete remission eliminated a genetic defect. TLR expression and function were also affected to some degree in other diseases characterised by a strong acute phase response.
CONCLUSION: These data suggest activation of TLR7 during the active phase of PMR and GCA which resolves with complete disease remission. Whether this finding is the consequence of the marked inflammatory process in these disorders or activation by natural ligands remains to be explored.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670089     DOI: 10.1136/ard.2010.140194

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

1.  Vascular involvement in cardiac giant cell myocarditis: a new pathophysiological aspect.

Authors:  S Elezkurtaj; D Lassner; H-P Schultheiss; F Escher
Journal:  Clin Res Cardiol       Date:  2013-11-20       Impact factor: 5.460

Review 2.  Toll-like receptor polymorphisms and vasculitis susceptibility: meta-analysis and systematic review.

Authors:  Gwan Gyu Song; Sung Jae Choi; Jong Dae Ji; Young Ho Lee
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

Review 3.  Chronic inflammation and aging: DNA damage tips the balance.

Authors:  Mary M Cavanagh; Cornelia M Weyand; Jörg J Goronzy
Journal:  Curr Opin Immunol       Date:  2012-05-05       Impact factor: 7.486

4.  Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  María Teresa Arias-Loste; Paula Iruzubieta; Ángela Puente; David Ramos; Carolina Santa Cruz; Ángel Estébanez; Susana Llerena; Carmen Alonso-Martín; David San Segundo; Lorena Álvarez; Antonio López Useros; Emilio Fábrega; Marcos López-Hoyos; Javier Crespo
Journal:  Int J Mol Sci       Date:  2016-11-10       Impact factor: 5.923

5.  Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFNγ and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells.

Authors:  María Teresa Arias-Loste; Joaquín Cabezas; Susana Llerena; Paula Iruzubieta; David San-Segundo; David Merino; Antonio Cuadrado; José Pedro Vaqué; Marcos López-Hoyos; Javier Crespo
Journal:  Viruses       Date:  2021-04-07       Impact factor: 5.048

6.  New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine.

Authors:  Atsumu Osada; Chinatsu Sakuragi; Chisashi Toya; Akiko Mitsuo
Journal:  Intern Med       Date:  2021-12-11       Impact factor: 1.271

7.  Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Yannick van Sleen; Jacoba C Graver; Wayel H Abdulahad; Kornelis S M van der Geest; Annemieke M H Boots; Maria Sandovici; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.